Edgewise Therapeutics Inc

1
NAS:EWTX (USA)  
$ 21.36 +0.51 (+2.45%) 10:08 PM EST
At Loss
P/B:
3.72
Volume:
637.23K
Avg Vol (2M):
794.59K
Trade In:
Volume:
637.23K
At Loss
Avg Vol (2M):
794.59K

Business Description

Edgewise Therapeutics Inc
NAICS : 325412 SIC : 2834
ISIN : US28036F1057
Description
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 101.5
Equity-to-Asset 0.97
Debt-to-Equity 0.01
Debt-to-EBITDA -0.04
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 50.38
9-Day RSI 56.68
14-Day RSI 58.38
6-1 Month Momentum % 24.08
12-1 Month Momentum % 126.29

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 37.08
Quick Ratio 37.08
Cash Ratio 36.49

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -14.8
Shareholder Yield % -12.08
Name Current Vs Industry Vs History
ROE % -29.66
ROA % -28.12
ROIC % -698.67
ROC (Joel Greenblatt) % -963.51
ROCE % -34.14

Financials (Next Earnings Date:2024-08-09 Est.)

EWTX's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:EWTX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Edgewise Therapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -1.55
Beta 0.25
Volatility % 103.48
14-Day RSI 58.38
14-Day ATR ($) 1.2524
20-Day SMA ($) 19.921
12-1 Month Momentum % 126.29
52-Week Range ($) 5.12 - 23.5
Shares Outstanding (Mil) 93.41

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Edgewise Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Edgewise Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Edgewise Therapeutics Inc Frequently Asked Questions

What is Edgewise Therapeutics Inc(EWTX)'s stock price today?
The current price of EWTX is $21.36. The 52 week high of EWTX is $23.50 and 52 week low is $5.12.
When is next earnings date of Edgewise Therapeutics Inc(EWTX)?
The next earnings date of Edgewise Therapeutics Inc(EWTX) is 2024-08-09 Est..
Does Edgewise Therapeutics Inc(EWTX) pay dividends? If so, how much?
Edgewise Therapeutics Inc(EWTX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1